An NCI-designated Comprehensive Cancer Center
By City of Hope | December 16, 2016

Cancer in the bloodstream can be just as aggressive as cancers that form solid masses.

Fortunately, the long-term strategies offered by City of Hope’s Hematologic Malignancies (HM) Program have dramatically improved the lives of patients with leukemia, lymphoma, Hodgkin’s disease and multiple myeloma.

Here with thoughts on what City of Hope offers your patients is Steven T. Rosen, M.D., provost and chief scientific officer.

Subscribe to Physician News for the latest developments in diabetes and cancer prevention, treatment, research, clinical trials and upcoming continuing medical education (CME) programs.
We will always respect your privacy and you may unsubscribe at any time. We will never sell or exchange your information with others. View our complete Privacy Policy .

*Required Fields